Co-Diagnostics, Inc. Continues to Execute on International Expansion
Company completes sale and installation to one of the largest private molecular diagnostics labs in Ghana
[…]
Company completes sale and installation to one of the largest private molecular diagnostics labs in Ghana
[…]
MIRAMAR, Fla., Oct. 28, 2019 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph […]
THIS INTERVIEW HAS EXPIRED
About: Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. We have two areas of focus: 1) a specialized biotherapeutics segment dedicated […]
Pro-Dex, Inc. specializes in the design, development and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic and maxocranial facial markets. […]
Active Ingredient in SGX301 for the Treatment of
Cutaneous T-Cell Lymphoma […]
New York City, Oct. 15, 2019 (GLOBE NEWSWIRE) — Co-Diagnostics Plans Product Launch for Emerging Mosquito Threat EEE Virus as Demand Grows New York City, New York – News yesterday from Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech with […]
THIS INTERVIEW HAS EXPIRED
Click here for corporate deck INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street, this is Juan Costello, Senior analyst with the Wall Street Analyzer. Joining us today is Michael Jennings CEO for Next Green Wave […]
Key products to be tested, registered and marketed include Insugin for diabetes application, alternative insulin for Alzheimer’s application, and Blood Plasma Derived Products, Human Serum Albumin 20% […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com